SCHOTT Pharmaceutical Packaging, a division of SCHOTT North America, Inc., has announced that the Lebanon, PA facility has completed facility and equipment validations of its syringe production line, expanding production capacities for North American customers. The announcement is a first for the facility, which last year undertook more than $14 million in capital investments, including the creation of more than 40 new jobs.
In addition, SCHOTT Pharmaceutical Packaging announced the product validation for its first ready-to-fill syringe customer, with several others in process. This is a major milestone and addition for the Lebanon facility which has traditionally manufactured high-quality vials and cartridges for the pharmaceutical industry. To date, syringes have been produced in Switzerland and imported to the US market.
“We have completed operational qualification of the syringe wash line,” said Renard Jackson, Vice President of SCHOTT North America, Inc. and General Manager of its Pharmaceutical Packaging Division. “We are now prepared to assist additional customers with their commercial production requirements for ready-to-fill syringes.”
With the addition of ready-to-fill syringes to its portfolio of vials, ampoules and cartridges, the entire complement of SCHOTT pharmaceutical packaging products is now produced in North America. SCHOTT is only the second company to produce high quality ready-to-fill syringes in the United States.
SCHOTT products and production processes conform to the U.S. Food and Drug Administration’s good manufacturing practice (cGMP) standards. The production line incorporates the most advanced technologies, including dimensional camera inspection and clean room final packaging.
SCHOTT has been producing pharmaceutical products in the United States since 1992.
